Navigation

Rheumatoid arthritis - tocilizumab (rapid review TA198)

Rheumatoid arthritis - tocilizumab (rapid review TA198)

Status: History
Expected date of issue: February 2012
Referral date: July 2008
Process: STA
Notes:

This STA is following the rapid review process

Topic area:
  • Musculoskeletal
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Emma Stewart
Communications manager: Tonya Gillis
Project manager: Lori Farrar
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: Not applicable for this topic
1st appraisal committee meeting: 14 September 2011
2nd appraisal committee meeting 08 November 2011
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Roche Products (tocilizumab)

Patient/carer groups

  • Arthritis & Musculoskeletal Alliance (ARMA)
  • Arthritis Care
  • National Rheumatoid Arthritis Society

Professional groups

  • British Health Professionals in Rheumatology
  • British Society for Rheumatology
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians

Others

  • Department of Health
  • Welsh Assembly Government

General

  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Possible comparator manufacturer(s)

  • Abbott Laboratories (adalimumab)
  • AstraZeneca UK (chloroquine)
  • GlaxoSmith Kline (azathioprine)
  • Novartis (ciclosporin)
  • Pfizer (methotrexate, sulfasalazine, etanercept)
  • Roche Products (rituximab)
  • Sanofi Aventis (hydroxychloroquine, leflunomide, sodium aurothiomalate)
  • Schering-Plough (infliximab)

Relevant research groups

  • None

Evidence Review Group

  • West Midlands Health Technology Assessment Collaboration
  • National Institute for Health Research (NIHR) Health Technology Assessment Programme (HTA Programme)

Associated guideline groups

  • None

Associated public health groups

  • None

Top


 

Key documents

This page was last updated: 20 February 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.